GlassScriptPhysician profile
Karim A Paracha
NPI 1316128937
$12,929.43
in general payments reported to CMS, 2019-2025
15 companies · $1,439 in 2025
The $1,439 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.24 · 2021: $12.19 · 2022: $10K · 2023: $561 · 2024: $803 · 2025: $1,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,802.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,672.60 | 2022 | |
| Integra Lifesciences Corporation | $967.00 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tela Bio, INC. | $413.68 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $351.40 | 2022-2024 | Phasix Mesh |
| Tactile Systems Technology INC | $331.26 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Organogenesis INC. | $264.11 | 2022-2025 | Puraply, Puraply Wound Matrix |
| Advanced Oxygen Therapy INC. | $237.56 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Smith+Nephew, INC. | $211.47 | 2024-2025 | Grafix Pl, Collagenase Santyl, Grafix |
| Solventum Corporation | $205.26 | 2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Boston Scientific Corporation | $124.34 | 2022 | |
| Kerecis Limited | $83.23 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $25.76 | 2021-2022 | |
| Tei Biosciences INC | $14.81 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.52 | 2022 | |
| Merck Sharp & Dohme LLC | $13.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karim Paracha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.